This article reviews the characteristics and possible mechanisms of IL-6 changes in various diseases associated with OD to provide evidence for the clinical application of IL-6 as a biomarker of OD and to promote in-depth exploration of its mechanism of action in the occurrence and development of OD. This evidence concerns the gene IL6 and osteochondritis dissecans.